Last reviewed: 28 Sep 2021
Last updated: 28 Oct 2021

Summary

Differentials

Common

  • Polycystic ovary syndrome
  • Idiopathic hirsutism

Uncommon

  • Hyperprolactinemia
  • Nonclassic congenital adrenal hyperplasia
  • Cushing syndrome (benign)
  • Androgenic medications
  • Androgen-secreting ovarian tumor
  • Ovarian hyperthecosis
  • Adrenocortical carcinoma

Contributors

Authors

Stephen L. Atkin, PhD, FRCP

Professor of MedicineHead of School of Postgraduate Studies & Research

The Royal College of Surgeons in Ireland - Bahrain

Busaiteen

Bahrain

Disclosures

SLA has received funds for an investigator-initiated study and delivered educational lectures for Novo Nordisk.

Thozhukat Sathyapalan, MD, MRCP FRCPE

Professor of Endocrinology/Honorary Consultant Endocrinologist

Academic Endocrinology, Diabetes and Metabolism

Hull York Medical School

Michael White Diabetes Centre

Hull Royal Infirmary

Hull

UK

Disclosures

TS declares that he has no competing interests.

Acknowledgements

Dr Stephen L. Atkin and Dr Thozhukat Sathyapalan would like to gratefully acknowledge Dr Shehzad Basaria and Dr Milena Braga-Basaria, the previous contributors to this topic.

Disclosures

SB and MBB declared that they had no competing interests.

Peer reviewers

Joe McKenna, MD

Professor of Investigative Endocrinology

University College

Dublin

Ireland

Disclosures

JM declares that he has no competing interests.

Udaya Kabadi, MD, FRCP(C), FACP, FACE

Director

Endocrinology

Department of Internal Medicine

VA Medical Center

University of Iowa

Iowa City

IA

Disclosures

UK declares that he has no competing interests.

Use of this content is subject to our disclaimer